Same Indication

Ipilimumab vs Moxifloxacin

Ipilimumab vs Moxifloxacin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Moxifloxacin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Moxifloxacin — 12 hours.

Chemical Properties

Molecular Formula: Moxifloxacin — C21H24FN3O4.

Molecular Weight: Moxifloxacin — 401.4350 g/mol.

Type: Ipilimumab — Antibody; Moxifloxacin — Small molecule.